BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 33131577)

  • 1. Impact of facility type on survival after pancreatoduodenectomy for small pancreatic adenocarcinoma (≤ 2 cm).
    Maegawa FB; Ashouri Y; Bartz-Kurycki M; Ahmad M; De La Rosa E; Philipovskiy A; Riall TS; Konstantinidis IT
    Am J Surg; 2021 Jul; 222(1):145-152. PubMed ID: 33131577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Para-aortic lymph nodes and ductal adenocarcinoma of the pancreas: Distant neighbors?
    Safi SA; Rehders A; Haeberle L; Fung S; Lehwald N; Esposito I; Ziayee F; Krieg A; Knoefel WT; Fluegen G
    Surgery; 2021 Dec; 170(6):1807-1814. PubMed ID: 34392977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Facility volume-survival relationship in patients with early-stage pancreatic adenocarcinoma treated with neoadjuvant chemotherapy followed by pancreatoduodenectomy.
    Hue JJ; Sugumar K; Markt SC; Hardacre JM; Ammori JB; Rothermel LD; Winter JM; Ocuin LM
    Surgery; 2021 Jul; 170(1):207-214. PubMed ID: 33454134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncological outcome of laparoscopically assisted pancreatoduodenectomy for ductal adenocarcinoma in a retrospective cohort study.
    Kuesters S; Chikhladze S; Makowiec F; Sick O; Fichtner-Feigl S; Hopt UT; Wittel UA
    Int J Surg; 2018 Jul; 55():162-166. PubMed ID: 29807171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The treatment sequence may matter in patients undergoing pancreatoduodenectomy for early stage pancreatic cancer in the era of modern chemotherapy.
    Watson MD; Thompson KJ; Musselwhite LW; Hwang JJ; Baker EH; Martinie JB; Vrochides D; Iannitti DA; Ocuin LM
    Am J Surg; 2021 Jul; 222(1):159-166. PubMed ID: 33121658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Nomogram for patients undergoing radical Pancreaticoduodenectomy for adenocarcinoma of the pancreatic head.
    Wu C; Hou SZ; Wu Z; Huang X; Wang Z; Tian B
    BMC Cancer; 2021 May; 21(1):624. PubMed ID: 34044806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. International validation and update of the Amsterdam model for prediction of survival after pancreatoduodenectomy for pancreatic cancer.
    van Roessel S; Strijker M; Steyerberg EW; Groen JV; Mieog JS; Groot VP; He J; De Pastena M; Marchegiani G; Bassi C; Suhool A; Jang JY; Busch OR; Halimi A; Zarantonello L; Groot Koerkamp B; Samra JS; Mittal A; Gill AJ; Bolm L; van Eijck CH; Abu Hilal M; Del Chiaro M; Keck T; Alseidi A; Wolfgang CL; Malleo G; Besselink MG
    Eur J Surg Oncol; 2020 May; 46(5):796-803. PubMed ID: 31924432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Surgical therapy of pancreatic cancer - 5 years survival].
    Loveček M; Skalický P; Klos D; Neoral Č; Ehrmann J; Zapletalová J; Švébišová H; Yogeswara T; Ghothim M; Vrba R; Havlík R
    Rozhl Chir; 2015 Nov; 94(11):470-6. PubMed ID: 26766155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative serum C-reactive protein levels and post-operative lymph node ratio are important predictors of survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
    Sanjay P; de Figueiredo RS; Leaver H; Ogston S; Kulli C; Polignano FM; Tait IS
    JOP; 2012 Mar; 13(2):199-204. PubMed ID: 22406601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experience.
    Winter JM; Cameron JL; Campbell KA; Arnold MA; Chang DC; Coleman J; Hodgin MB; Sauter PK; Hruban RH; Riall TS; Schulick RD; Choti MA; Lillemoe KD; Yeo CJ
    J Gastrointest Surg; 2006 Nov; 10(9):1199-210; discussion 1210-1. PubMed ID: 17114007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the lymph node ratio in pancreatic ductal adenocarcinoma. Impact on patient stratification and prognosis.
    La Torre M; Cavallini M; Ramacciato G; Cosenza G; Rossi Del Monte S; Nigri G; Ferri M; Mercantini P; Ziparo V
    J Surg Oncol; 2011 Nov; 104(6):629-33. PubMed ID: 21713779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Total pancreatectomy for pancreatic ductal adenocarcinoma: review of the National Cancer Data Base.
    Johnston WC; Hoen HM; Cassera MA; Newell PH; Hammill CW; Hansen PD; Wolf RF
    HPB (Oxford); 2016 Jan; 18(1):21-8. PubMed ID: 26776847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The number of lymph nodes identified in a simple pancreatoduodenectomy specimen: comparison of conventional vs orange-peeling approach in pathologic assessment.
    Adsay NV; Basturk O; Altinel D; Khanani F; Coban I; Weaver DW; Kooby DA; Sarmiento JM; Staley C
    Mod Pathol; 2009 Jan; 22(1):107-12. PubMed ID: 18820663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution and impact of lymph node dissection during pancreaticoduodenectomy for pancreatic cancer.
    Eskander MF; de Geus SW; Kasumova GG; Ng SC; Al-Refaie W; Ayata G; Tseng JF
    Surgery; 2017 Apr; 161(4):968-976. PubMed ID: 27865602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term survival after pancreatoduodenectomy for ductal adenocarcinoma: the emperor has no clothes?
    Bradley EL
    Pancreas; 2008 Nov; 37(4):349-51. PubMed ID: 18953246
    [No Abstract]   [Full Text] [Related]  

  • 16. Regional pancreatoduodenectomy versus standard pancreatoduodenectomy with portal vein resection for pancreatic ductal adenocarcinoma with portal vein invasion.
    Oba A; Ito H; Ono Y; Sato T; Mise Y; Inoue Y; Takahashi Y; Saiura A
    BJS Open; 2020 Jun; 4(3):438-448. PubMed ID: 32191395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of the American Joint Committee on Cancer 8th edition staging system for the pancreatic ductal adenocarcinoma.
    Shin DW; Lee JC; Kim J; Woo SM; Lee WJ; Han SS; Park SJ; Choi KS; Cha HS; Yoon YS; Han HS; Hong EK; Hwang JH
    Eur J Surg Oncol; 2019 Nov; 45(11):2159-2165. PubMed ID: 31202572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metastatic lymph node ratio as an important prognostic factor in pancreatic ductal adenocarcinoma.
    Robinson SM; Rahman A; Haugk B; French JJ; Manas DM; Jaques BC; Charnley RM; White SA
    Eur J Surg Oncol; 2012 Apr; 38(4):333-9. PubMed ID: 22317758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival Trends for Resectable Pancreatic Cancer Using a Multidisciplinary Conference: the Impact of Post-operative Chemotherapy.
    Syed AR; Carleton NM; Horne Z; Dhawan A; Bedi G; Kochhar G; Morrissey S; Williams H; Atkinson D; Schiffman S; Monga D; Lupetin A; Kirichenko A; Mitre M; Dhawan M; Kulkarni A; Thakkar S
    J Gastrointest Cancer; 2020 Sep; 51(3):836-843. PubMed ID: 31605289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Which patients with para-aortic lymph node (LN16) metastasis will truly benefit from curative pancreaticoduodenectomy for pancreatic head cancer?
    Liu C; Lu Y; Luo G; Cheng H; Guo M; Liu Z; Xu J; Long J; Liu L; Fu D; Ni Q; Li M; Yu X
    Oncotarget; 2016 May; 7(20):29177-86. PubMed ID: 27081079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.